a public good project by the
Synthesis
Company
of California

© 2026

Émile Bisagni | doi.page

0 works0 citations0 h-index

Émile Bisagni

Centre National de la Recherche Scientifique(FR)Johnson & Johnson (United States)(US)

Publications by Year

Research Areas

Synthesis and Biological Evaluation, Cancer therapeutics and mechanisms, Synthesis and Reactivity of Heterocycles, Bioactive Compounds and Antitumor Agents, Synthesis and Reactions of Organic Compounds

Most-Cited Works

→ Triple Helix-Specific Ligands(1992)283 cited
→ Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides(1990)200 cited
→ Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice(1979)117 cited
→ Biological effects and repair of damage photoinduced by a derivative of psoralen substituted at the 3,4 reaction site Photoreactivity of this compound and lethal effect in yeast(1978)112 cited
→ Diphenyl quinolines and isoquinolines: synthesis and primary biological evaluation(2000)110 cited
→ Rational design of a triple helix-specific intercalating ligand(1998)109 cited

→ Synthesis and evaluation of new 6-amino- substituted benzo[c]phenanthridine derivatives(1993)

108 cited

→ 5-Methoxypsoralen, the melanogenic additive in sun-tan preparations, is tumorigenic in mice exposed to 365 nm u.v. radiation(1981)98 cited

→ A New Series of Pyridinone Derivatives as Potent Non-Nucleoside Human Immunodeficiency Virus Type 1 Specific Reverse Transcriptase Inhibitors(1995)97 cited

Intoplicine (RP 60475) and its derivatives, a new class of antitumor agents inhibiting both topoisomerase I and II activities.(1993)